Hyderabad, March 27 -- ASPIRE-BioNEST at the University of Hyderabad (UoH) on Friday signed a Memorandum of Understanding (MoU) with Indian Immunologicals Ltd. (IIL) to accelerate biotechnology innovation under the One Health framework.
The partnership will support startups in areas such as therapies, diagnostics, and medical devices by enabling co-development, validation, technology transfer, and market access, with a focus on translating research into market-ready products.
The MoU was exchanged between IIL Director Dr Anand Kumar and ASPIRE-BioNEST Director Prof S Rajagopal in the presence of senior officials from both organisations.
Published by HT Digital Content Services with permission from United News of India....